Can Early Metformin Reduce the Risk of Long-COVID?
Metformin has shown activity against the SARS-CoV-2 in human lung tissue ex vivo at a physiologically relevant dose. Read the findings from a randomized phase 3 trial that explored the effect of metformin on the risk of long COVID development when given early to COVID-19 outpatients.
mRNA Vaccines May Neutralize SARS-CoV-2 Virus in Nasal Mucosa
Intramuscular mRNA vaccines against the SARS-CoV-2 exponentially increase the systemic production of virus-specific IgG and IgA antibodies. However, its effect on antibody production or neutralizing virus within the nasal mucosa is unknown.
Ruling Out Preeclampsia in a Pregnant COVID-19 Patient
A 39-year-old G5P1 pregnant woman (26 weeks of gestation) presented with worsening dyspnea and cough. The symptoms had started five days ago. A multidisciplinary team of experts in general medicine, infectious disease, and maternal-fetal medicine discussed the possibility of preeclampsia in the patient.
How Can You Biochemically Differentiate Between COVID-19 and MIS-C?
Multisystem inflammatory syndrome in children (MIS-C) is associated with COVID-19. The current diagnosis of MIS-C relies primarily on clinical symptoms and therefore it is often misdiagnosed. To effectively differentiate between COVID-19 and MIS-C, researchers analyzed blood samples of 237 pediatric patients with COVID-19 or MIS-C to reveal the distinct nucleic acid biomarkers involved in each condition. Read to know what they found.
Docplexus: One of the world's largest online communities of Doctors Pune - 411025, INDIA info@docplexus.co.in | +91-98500 36954
|
Friday, July 21, 2023
Can Early Metformin Reduce the Risk of Long-COVID?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment